Navigation Links
Perrigo Company plc Reports Record Fourth Quarter And Fiscal Year Revenue, Adjusted Operating Income And Adjusted Margins
Date:8/14/2014

DUBLIN, Aug. 14, 2014 /PRNewswire/ --

  • Fiscal fourth quarter net sales increased 18% year-over-year to a record $1.14 billion.
  • Fiscal fourth quarter adjusted net income increased 58% to $234 million, or $1.74 per diluted share; GAAP net income of $132 million, or $0.98 per diluted share, includes amortization expense and other charges.
  • Record quarterly adjusted gross margin of 44.5%, with GAAP gross margin of 36.3% and record quarterly adjusted operating margin of 28.4%, with GAAP operating margin of 17.3%.
  • Fiscal 2014 net sales increased 15% year-over-year to a record $4.06 billion, with organic growth of 7%.
  • Fiscal 2014 adjusted net income increased 40% to $740 million or $6.39 per diluted share; GAAP net income of $205 million, or $1.77 per diluted share, includes amortization expense and other charges.
  • Management expects full-year fiscal 2015 adjusted earnings range of $7.20 to $7.50 per diluted share, an increase of 13% to 17% over fiscal 2014 adjusted earnings per share, and reported earnings of between $4.05 and $4.35 per diluted share.
  • Perrigo Company plc (NYSE: PRGO; TASE) today announced results for its fourth quarter and fiscal year ended June 28, 2014.

    Perrigo's Chairman, President and CEO Joseph C. Papa commented, "I am pleased to report that Perrigo has delivered year-over-year record sales and adjusted earnings for the ninth straight fiscal year. While the year was not without its challenges, including an historically weak cough/cold season among other headwinds, this team was able to deliver record results. I am proud of our top line organic growth of 7%, driven by $231 million in new product sales and great execution in our business segments. We transformed Perrigo
    '/>"/>

    SOURCE Perrigo Company plc
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

    Related medicine technology :

    1. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
    2. Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance
    3. Perrigo Company to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference
    4. Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules
    5. Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
    6. Perrigo Announces FDA Final Approval Of Tris Pharmas Dextromethorphan Polistirex Extended-Release Oral Suspension
    7. Perrigo Company To Present At The William Blair Growth Stock Conference
    8. Perrigo Receives FDA Approval And Commences Launch Of Clobetasol Propionate Shampoo, 0.05%
    9. Perrigo Company Announces Quarterly Dividend
    10. Perrigo Company To Present At The Morgan Stanley Global Healthcare Conference
    11. Perrigo Company To Acquire Assets Of Sergeants Pet Care Products, Inc., For $285 Million
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/16/2014)... 2014 Adaptive Biotechnologies, a clinical stage diagnostics ... the adaptive immune system, is pleased to announce the ... Officer (CCO). The addition of Brain to the Company,s ... leading global healthcare companies, including Dean Schorno ... Genomic Health and Sean Nolan (CTO) from ...
    (Date:9/16/2014)... , Sept. 16, 2014 QPID Health , ... to new headquarters in Boston and ... headquarters will be at 175 Franklin Street in ... marketing teams. QPID Health,s new Southern California ... Carlsbad.  The expansion will help meet the demands of customers ...
    (Date:9/16/2014)... , Sept. 16, 2014  Formex, ... manufacturing, announced that Mr. Greg Weilersbacher joined Formex ... 25, 2014. Greg Weilersbacher ... experience with focused expertise in Quality Assurance, ... Mr. Weilersbacher brings to Formex a ...
    Breaking Medicine Technology:Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 2Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 3QPID Health Announces Major Office Expansion in Boston and Opens Facility in San Diego 2Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control 2
    ... Amgen (Nasdaq: AMGN ) today announced ... had significantly greater adherence, compliance, and persistence during ... oral bisphosphonate commonly used to treat osteoporosis. ... compliance (a measure of how well patients follow ...
    ... March 23, 2011 NephRx Corporation today announced issuance ... novel growth factor peptide NX002 as a potential treatment ... NX002 may have applications in acute and chronic diseases ... colitis.  It has been shown to stimulate the growth ...
    Cached Medicine Technology:Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 2Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 3Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 4Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 5Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 6Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 7Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 8Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 9Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 10Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 11NephRx Corp. Awarded U.S. Patent for Use of Novel Growth Factor Peptide NX002 in Inflammatory Bowel Disease 2
    (Date:9/16/2014)... September 16, 2014 Advanced Fertility Center ... named by Houstonia Magazine as one of the Top ... Houstonia Magazine - a metropolitan magazine serving the Houston ... and recognize them for their outstanding services. This accomplishment ... edition of Houstonia Magazine — a special publication listing ...
    (Date:9/16/2014)... Orlando, Florida (PRWEB) September 16, 2014 These ... the last 3 years to receive up to $10,000 in ... This program, as well as other state and federal programs, ... have to be paid back until you sell or move ... loan is a 0% interest loan. There are no monthly ...
    (Date:9/16/2014)... Aspen Advisors, a U.S.-based healthcare IT consulting firm, ... high morale and collaborative culture in the ... Work For 2014.” Consulting magazine publishes the popular ... participating across all major industries, representing more than 350 ... firms were ranked in six categories - firm culture, ...
    (Date:9/16/2014)... WASHINGTON, DC September 14, 2014 ... of everolimus-eluting stents (EES) and drug-eluting balloons ... drug-eluting stents found that EES provided superior ... outcomes. , Findings were reported today ... (TCT) scientific symposium. Sponsored by the Cardiovascular ...
    (Date:9/16/2014)... absorbs the right balance of nitrogen, phosphorus and potassium ... Kansas State University study finds. , A review of ... and other regions showed that high yields were linked ... key nutrients at specific ratios - nitrogen and phosphorus ... at a ratio of 1-to-1. These nutrient uptake ratios ...
    Breaking Medicine News(10 mins):Health News:Dr. Michael Allon Receives Esteemed Recognition 2Health News:New Updated 2014 First Time Home Buyer Programs Available to Florida Residents 2Health News:New Updated 2014 First Time Home Buyer Programs Available to Florida Residents 3Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 2Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 3Health News:Results of RIBS IV trial reported at TCT 2014 2Health News:Boosting global corn yields depends on improving nutrient balance 2Health News:Boosting global corn yields depends on improving nutrient balance 3
    ... proteins CCSA-3 and CCSA-4, present in blood that accurately ... used to develop a blood test to identify ... a team of researchers led by Robert Getzenberg at ... proteins were first discovered by Getzenberg and colleagues at ...
    ... a tough task to answer who has the best pair of ... has pinned down the top ten beauties with the hottest legs. ... with the sexiest pair of legs, reports The Sun. ... the top slot. ,American R and B singer Beyonce ...
    ... socialite Paris Hilton has been getting a princess' treatment in ... to inmates, the 26-year-old is living in 'Lean Cuisine' style ... nuggets and fish that others would never get. ... of the women's jail in Lynwood, California, from a Los ...
    ... in daisy gravy, carnation and herb salad, nasturtium sauce -- ... the plate . ,"Flowers have been used for ... very secondary way", culinary historian Patrick Rambourg told AFP. "In ... the floor during banquets to perfume the room." , ...
    ... amended a law to ban circuses from importing or ... of animal rights, a legislator said Friday . ... Thursday, all imports and exports of animals such as ... are needed for research, said Tien Chiu-chin, of the ...
    ... links between alcohol, drugs and risky sexual behaviour are ... a government advisory body report said Friday . ... in the last 12 years, and media coverage of ... Independent Advisory Group on Sexual Health and HIV said. ...
    Cached Medicine News:Health News:Flower-power on a Plate in Paris 2Health News:Drink and Drugs 'fuel British Sexual Health Crisis' 2
    ... reagent once reconstituted offers the laboratory all ... help maximize laboratory productivity, minimize operator error ... patented technology of the Infinity Urea (Nitrogen) ... and stability once reconstituted that will minimize ...
    ... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The proprietary ... reagent provides a long shelf life ...
    ... Triglycerides powder reagent once reconstituted offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... powder reagent provides a long shelf ...
    ... Oxidase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Oxidase reagent provides a long shelf ...
    Medicine Products: